Insider · CIK 0001720634
Federico Grossi
Files at UBX (Unity Biotechnology, Inc.). First filing -, latest -.
Federico Grossi files SEC Form 4 as officer at UBX (Unity Biotechnology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Federico Grossi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | UBX Unity Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Jan 7, 2025 |
Questions about Federico Grossi
Answered from the filings on this page, as of the latest one.
Is Federico Grossi buying or selling?
Federico Grossi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Federico Grossi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Federico Grossi has 0.
Where does Federico Grossi file Form 4?
Federico Grossi has filed Form 4 at UBX (Unity Biotechnology, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.